Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
Txylo.com/10281578
Trending...
- How Technology is Making the Florida Court System More Accessible
- Jason's Deli Unveils Bold New Brand Identity and Restaurant Prototype, Marking the Brand's Next Iteration
- Governor Abbott Directs Texas State Agencies To Reject Woke Gender Ideologies
TEMECULA, Calif. - Txylo -- 16Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on Txylo.com
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on Txylo.com
- Flywheelr Redefines Executive Thought Leadership as the New Face of B2B Marketing
- Varsity Brands Strengthens Leadership Team with Two Key Executive Appointments
- Texas: Governor Abbott Spotlights Rural Support For School Choice In Athens
- Kelvin Emtech and Colm Engineering Unveil Strategic Joint Venture, to Boost Data Center and Building M&E Capabilities
- Announcing Rooted in Rhythm: A Celebration of Emerging Artists in Country Music
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
Source: Longevity by Nature
Filed Under: Health
0 Comments
Latest on Txylo.com
- City of Sanger Recognizes Shani Bradshaw for Leadership in Bringing Tom Thumb Grocery Store
- Governor Abbott Reappoints McCleskey As Independent Ombudsman For The Texas Juvenile Justice Department
- "FUSE: Premier Office Spaces with Hospitality-Driven Flexibility for Startups & Enterprises"
- Patton Launches SFP-based RS-232/422/485 Serial Device Server
- Texas: Governor Abbott Reappoints Three To Real Estate Research Advisory Committee
- Local Tech Entrepreneur Partners with WonderSouq To Offer Downtown Medford Businesses a Virtual City Experience
- The Continental, powered by Placemakr Set to Launch in San Antonio
- Texas: Governor Abbott Announces Over $138,000 Job Training Grant To Victoria College
- Boston Bridal Atelier Enhances Luxury Experience with New Bridal Shop Location
- New Website for Solo Agers Over 50
- Malcolm-Jamal Warner Returns to Columbia for an Unforgettable Evening of Poetry & Music
- Slightly Stoopid, Damian & Stephen Marley to headline Everwild Music Festival in 2025
- GRAND CANYONS OF THE MOON
- Parkbench13 Media Group Inc. Seeks Artists for Sync Licensing Opportunities
- The Elevated Table Project Revolutionizes Cannabis-Infused Cooking & Cocktails
- South By Southwest Launches SXSW Books Imprint in Partnership with Advantage Media
- Sano Chemicals Inc. (DBA "Sano Women's Health") Announces Approval to Start Phase 1 MAD Study
- Private AI Leader webAI Announces Deal with ŌURA to Power Personalized, On-Device AI
- Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications
- THSYU Opens New Doors for Accredited Investors, Bridging the Gap Between Traditional Finance and the Digital Asset Frontier